The HNR1.SW stock is trading at CHF219.00 in pre-market trade on 09 Mar 2026, a +37.74% move from the previous close of CHF159.00. This sharp percentage jump arrives ahead of Hannover Rück SE’s scheduled earnings on 12 Mar 2026. The move is notable for its price action but not for volume, with only 25 shares reported so far versus an average of 24,790. Investors should weigh the valuation signals, including EPS 18.67 and PE 11.73, against the upcoming results and sector trends in Swiss financial services

HNR1.SW stock pre-market price and volume

The stock opened pre-market at CHF219.00, up CHF60.00 or 37.74% from the prior close. The percentage move makes HNR1.SW a high-mover in pre-market scans. Volume is light at 25 shares, well below the avgVolume 24,790, so the price move currently lacks heavy intraday participation.

HNR1.SW stock fundamentals and valuation

Hannover Rück SE shows EPS 18.67 and a trailing PE 11.73, implying value relative to the Financial Services sector average PE 17.26. Book value per share is 115.73 and price-to-book is 2.31, while dividend per share is 9.00, giving a dividend yield near 3.62%. Market capitalization stands at CHF26,407,502,019.00, which aligns with a large-cap reinsurer profile in Switzerland and Germany

HNR1.SW stock Meyka grade & forecast

Meyka AI rates HNR1.SW with a score out of 100: 72.11 | Grade B+ | Suggestion: BUY. This grade factors S&P 500 and sector comparisons, financial growth, key metrics, analyst consensus, and forecasts. Meyka AI, an AI-powered market analysis platform, uses this proprietary grade as a summary signal, not as advice

Meyka AI’s forecast model projects a yearly price of CHF173.34, against the current CHF219.00, implying a model-based downside of -20.85%. The three-year projection is CHF180.45, implying -17.56% from today. Forecasts are model-based projections and not guarantees

HNR1.SW stock technical outlook and sector context

Technical indicators are muted with price equal to the 50-day and 200-day averages at CHF219.00, so short-term trend signals are inconclusive. The reported RSI and MACD data are not meaningful in pre-market prints, so traders should wait for regular session liquidity. Hannover Rück sits in the Insurance – Life industry within Swiss-traded financial services, where peers show higher average PE ratios and mixed YTD returns

HNR1.SW stock risks and catalysts

Near-term catalysts include the earnings announcement on 12 Mar 2026, dividend policy clarity, and reinsurance cycle commentary. Key risks are low pre-market liquidity, exposure to catastrophe losses, currency fluctuations, and the possible gap between model forecasts and market reaction. CompanyRating data dated 28 Jan 2026 shows a third-party rating A, recommendation: Buy, which contrasts with Meyka’s model downside projections

Final Thoughts

HNR1.SW stock shows a dramatic pre-market price move to CHF219.00, rising +37.74%, but that move is set against minimal pre-market volume of 25 shares. Fundamentals remain solid: EPS 18.67, PE 11.73, PB 2.31, and a dividend yield around 3.62%. Meyka AI rates the stock 72.11/100 (B+, BUY) while also projecting a yearly model price of CHF173.34, which implies a -20.85% model downside from the current price. This juxtaposition highlights a key tension: market momentum versus model valuation. For traders focused on high-volume movers, the immediate trade opportunity is the percentage swing; for investors, the model forecast and underlying ratios warrant caution before adding exposure. Remember, Meyka AI’s projections and grades are model-based and not guarantees, and we are not financial advisors. Watch the 12 Mar 2026 earnings release and intraday liquidity on the SIX exchange before acting

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.